Hu Ruyin, Lei Pengfei, Li Bo, Liu Hao, Yang Xucheng, Wen Ting, Hu Yihe, Tian Xiaobin
Department of Orthopeadics, People's Hospital of Guizhou Province, No. 83 Zhongshan East Road, Guiyang, 550002, Guizhou, People's Republic of China.
Department of Orthopeadics, Xiangya Hospital Central South University, No. 87 Xiangya Road, Changsha, 410008, Hunan, People's Republic of China.
Int Orthop. 2018 Jul;42(7):1535-1544. doi: 10.1007/s00264-018-3899-6. Epub 2018 Mar 27.
This study was established to investigate the medium-term clinical effect of real-time CT assisted porous tantalum implant for the treatment of ARCO stage I-II non-traumatic osteonecrosis of the femoral head (ONFH).
This study comprised 24 ONFH patients (29 hips) who were treated with intra-operative real-time CT accurate rapid positioning assisted drilling decompression, lesion removal and porous tantalum implant. Harris score, VAS score and imaging in pre-operation and follow-up period were recorded.
The average operative time and intra-operative blood loss were 72.6 min and 158.8 ml, respectively. The mean follow-up was 5.4 years. No femoral head penetrating, wound infection, and death occurred. Harris and VAS score improved significantly (73.78 vs. 88.11; 7.13 vs. 2.66) at last follow-up (P < 0.05). The functional improvement and pain relief rate was 100% at six months after operation. The effective rate was 86.21% at 12 months after operation and last follow-up. Five pre-operative ARCO stage I hips had no radiographic progress. Meanwhile, four among the 24 ARCO stage II hips progressed into stage III between eight and 12 months after surgery, among which two progressed into stage IV and two remained in stage III at the last follow-up. The average value of Kerboul combined necrotic angle was 263.24°. There was no progress in Kerboul combined necrotic angle among the grades 2 and 3 patients. However, among the six cases at grade 4, four cases with post-operative progress, two patients converted to THA.
Our technique is safety and effective in the treatment of ARCO stage I-II non-traumatic ONFH.
本研究旨在探讨术中实时CT辅助多孔钽植入治疗ARCO I-II期非创伤性股骨头坏死(ONFH)的中期临床效果。
本研究纳入24例ONFH患者(29髋),接受术中实时CT精确快速定位辅助钻孔减压、病灶清除及多孔钽植入治疗。记录术前及随访期的Harris评分、VAS评分及影像学表现。
平均手术时间和术中出血量分别为72.6分钟和158.8毫升。平均随访5.4年。未发生股骨头穿透、伤口感染及死亡。末次随访时Harris和VAS评分显著改善(73.78 vs. 88.11;7.13 vs. 2.66)(P < 0.05)。术后6个月功能改善和疼痛缓解率为100%。术后12个月及末次随访时有效率为86.21%。术前5例ARCO I期髋关节无影像学进展。同时,24例ARCO II期髋关节中有4例在术后8至12个月进展为III期,其中2例进展为IV期,2例在末次随访时仍为III期。Kerboul联合坏死角平均值为263.24°。2级和3级患者的Kerboul联合坏死角无进展。然而,4级的6例中,4例术后有进展,2例转为全髋关节置换术(THA)。
我们的技术在治疗ARCO I-II期非创伤性ONFH方面安全有效。